October 27, 2021 — As part of Breast Cancer Awareness Month, Penn Medicine will be providing free breast cancer screenings, no insurance required, to women in need over the age of 40.

October 27, 2021 — Scientists from Skoltech, Philips Research, and Goethe University Frankfurt have trained a neural network to detect anomalies in medical images to assist physicians in sifting through countless scans in search of pathologies. Reported in ​​IEEE Access, the new method is adapted to the nature of medical imaging and is

October 27, 2021 — Carestream Health will highlight the imaging and workflow value of artificial intelligence (AI) in medical imaging at the Radiological Society of North America (RSNA

October 27, 2021 — The U.S. Food and Drug Administration (FDA), Health Canada, and the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency (MHRA) jointly issued the Good Machine Learning Practice for Medical Device Development: Guiding Principles.

October 27, 2021 — Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment. Researchers and clinicians from Memorial Sloan Kettering Cancer Center collaborated to test their lung cancer population.

October 27, 2021 — The time required to secure prior authorization approvals for radiation therapy treatments equates to a financial impact of more than $40 million annually for academic medical centers, according to a new study. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

October 25, 2021 — A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer. By identifying and addressing obstacles that kept patients from finishing radiation treatments for cancer, the intervention improved five-year survival rates for all patients and erased the survival gap between Black and white patients.

October 25, 2021 — A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy. The study, which examined biopsy samples collected from three large, randomized clinical trials, indicates that physicians potentially can use genetic test scores to personalize treatment for men with the most aggressive form of prostate cancer.

October 25, 2021 — Using fewer—but higher—doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows. Findings from the phase III NRG Oncology GU003 trial will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

October 24, 2021 — High-dose radiation therapy can be used to lengthen progression-free survival for people with advanced lung cancer when systemic therapy has not fully halted the growth or spread of metastases, according to a new study. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now